Remove the Cap on Social Security

I am apolitical by nature. The entire process of electing representatives, from city councils to Presidents, leaves me cold. Blame my extraordinary microeconomics professor H. Scott Bierman who was at Carleton... Read more »

Seattle Doesn’t Need a Biotech Anchor Tenant. It Needs to Be a Place Where Startups Thrive

Over the past week or so, I have been asked by a number of people, both privately and in the media, what I think about the acquisition of Seattle-based ZymoGenetics... Read more »

Seattle Is #3—Where Does Michigan Want To Be?

Seattle has, from my point of view, carved out its position as the No. 3 biotech market in the U.S. behind Boston and the San Francisco Bay Area. Michigan is currently... Read more »

Recruit Rock Star Scientists To Make Seattle Thrive as an Innovation Hub

I am quite often asked, in some form or another, “What can [STATE][LOCAL] government do to spur on an innovation-based economy in [SEATTLE][WASHINGTON]?”

Well, as I said on a panel at... Read more »

Diamonds Are Forever. Why Not a Drug Patent?

Tell me if this makes sense to you:

—If I buy a diamond, I can own it for as long as I like;

—If I produce a brand name for a... Read more »

Biotech in a Garage: It Can Work

(Editor’s Note: Carl Weissman submitted this in response to a feature story about entrepreneur Johnny Stine, who clearly relishes building a biotech startup without venture capital.)

Stickin’ it to the... Read more »

Death of Good Times? Hardly

I guess when you are Sequoia, you can hold a big public media-attended meeting where you display a faux tombstone ominously announcing the death of the Good Times. My approach... Read more »

Funding Gap? Ha!

Ever since I came back to Seattle in 2003 to help get Accelerator up and running, I have been barraged with rhetoric about something euphemistically referred to as the “Funding Gap.”... Read more »